The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 16, 2024

Filed:

Dec. 14, 2022
Applicant:

Eagle Pharmaceuticals, Inc., Woodcliff Lake, NJ (US);

Inventors:

Nagesh R. Palepu, Southampton, PA (US);

Philip Christopher Buxton, Uxbridge, GB;

Assignee:

Eagle Pharmaceuticals, Inc., Woodcliff Lake, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/08 (2006.01); A61K 47/10 (2017.01); A61K 47/18 (2017.01); A61P 35/00 (2006.01); A61K 31/4184 (2006.01); A61K 47/20 (2006.01); A61K 47/12 (2006.01); A61K 47/22 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4184 (2013.01); A61K 9/08 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/18 (2013.01); A61K 47/20 (2013.01); A61K 47/22 (2013.01); A61K 9/0019 (2013.01);
Abstract

Long term storage stable bendamustine-containing compositions are disclosed. The compositions can include bendamustine or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable fluid which can include in some embodiments PEG, PG or mixtures thereof and an antioxidant or chloride ion source. The bendamustine-containing compositions have less than about 5% total impurities, on a normalized peak area response ('PAR') basis as determined by high performance liquid chromatography (“HPLC”) at a wavelength of 223 nm, after at least about 15 months of storage at a temperature of from about 5° C. to about 25° C.


Find Patent Forward Citations

Loading…